Home
About Us
About Us
About Us
Team
Investors
Partners
Find out more about who we are, what we do and the people behind Epitopea.
Our Science
Our Science
CryptoMap
TM
Therapeutics Focus
Publications
Find out what makes us unique and the work we do with our revolutionary CryptoMap
TM
platform.
News & Events
News & Events
All News & Events
Press Releases
In the news
Events
All the latest company news, press releases and updates from Epitopea.
Language
Language
Français
English
Contact
News & Events:
In The News
Revealing the true targets for next generation immunotherapies.
Learn More
Epitopea featured in Cambridge Independent
Date:
November 4, 2024
|
In The News
Epitopea’s $31m pre-Series A is boost for RNA immunotherapies clinical trials Epitopea’s transatlantic business model has been boosted by a […]
Read More
Epitopea wins the 3rd annual Sweet BioPharma Day competition
Date:
April 14, 2023
|
In The News
Epitopea wins the 3rd annual Sweet BioPharma Day competition LAVAL, Québec--(BUSINESS WIRE)--BIOQuébec, CQDM, Fonds de solidarité FTQ and adMare BioInnovations, […]
Read More
Epitopea Featured in BioWorld
Date:
May 11, 2022
|
In The News
Epitopea closes $14M seed round for tumor antigen discovery Epitopea Ltd. raised $13.6 million in seed financing to take forward […]
Read More
Categories
In The News
Press Releases
Recent News & Events
Epitopea featured in Cambridge Independent
Epitopea Closes USD $31 million Pre-Series A Financing
CQDM and Epitopea Fund the Development and Validation of CryptoMapTM a Platform Enabling the Development of RNA-based Immunotherapies
Revealing Novel Targets For Next Generation Immunotherapies
Quick Links
Home
About Us
Platform
News & Events
Contact
Information
Careers
Disclaimer
Privacy & Cookie Policy
Terms & Conditions
Follow us on social media
© 2022 – 2024 Epitopea Ltd | All Rights Reserved
Created by
FDM Digital
linkedin-square
angle-down
